V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003521 | 210010645 | 1.55 | null | null | 2020-09-07 | 2020-09-09 | null | null | null | EC | 100132424 |
| 210003523 | 210010646 | 1.66 | 69.7 | null | 2019-11-19 | 2019-12-05 | EC | null | null | EC | 101699740 |
| 210003527 | 210010648 | 1.66 | 61.3 | Neo-adjuvant (N) | 2019-10-02 | 2019-10-04 | PERTUZUMAB + TRASTUZUMAB | null | N | PERTUZUMAB + TRASTUZUMAB | 101149906 |
| 210003530 | 210010649 | 1.63 | 80.5 | Palliative (P) | 2017-11-03 | 2017-11-03 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101298612 |
| 210003532 | 210010650 | null | null | null | 2018-05-01 | 2018-05-02 | Trial Unspecified | 02 | null | EC | 100669115 |
| 210003533 | 210010651 | null | 54.2 | null | 2017-04-24 | 2017-06-23 | EC | N | null | EC | 100241636 |
| 210003534 | 210010652 | 1.74 | 74.1 | null | 2019-03-01 | 2019-07-07 | Carboplatin + Docetaxel | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 100107612 |
| 210003536 | 210010653 | 1.7 | 90.2 | Palliative (P) | 2018-07-24 | 2018-08-22 | Capecitabine | null | N | CAPECITABINE | 101491473 |
| 210003539 | 210010655 | 1.63 | 55.8 | Palliative (P) | 2019-10-07 | 2019-10-07 | EC | 02 | N | EC | 101108235 |
| 210003540 | 210010656 | null | null | null | 2018-05-16 | 2018-10-02 | Eribulin | 02 | null | ERIBULIN | 100590453 |
| 210003541 | 210010657 | null | 93.65 | null | 2019-07-01 | 2019-07-22 | EC | 02 | null | EC | 100360541 |
| 210003544 | 210010660 | 1.67 | null | null | 2021-09-12 | 2021-11-01 | null | null | null | EPIRUBICIN | 101027596 |
| 210003545 | 210010661 | 1.42 | 55.75 | null | 2021-01-11 | 2021-03-28 | Carboplatin + Paclitaxel (weekly) | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100652043 |
| 210003547 | 210010662 | 1.79 | 63.5 | Adjuvant (A) | 2020-05-30 | 2020-06-16 | null | N | N | TCH | 100127664 |
| 210003551 | 210010663 | null | 55.4 | Palliative (P) | 2018-09-23 | 2018-09-30 | Palbociclib | 02 | N | LETROZOLE + PALBOCICLIB | 100945543 |
| 210003554 | 210010664 | null | 66.2 | null | 2018-01-21 | 2018-02-06 | null | 02 | null | ALECTINIB | 101431938 |
| 210003564 | 210010669 | null | 62.4 | null | null | 2020-10-15 | null | 01 | null | PACLITAXEL + TRASTUZUMAB | 100430523 |
| 210003565 | 210010670 | 1.61 | 78.7 | Palliative (P) | 2018-11-13 | 2019-03-06 | null | 02 | N | ABEMACICLIB + FULVESTRANT | 101379463 |
| 210003571 | 210010673 | 1.53 | 76.3 | null | null | 2021-10-18 | VINORELBINE | 02 | null | VINORELBINE | 101595631 |
| 210003580 | 210010676 | 0 | 79.35 | Neo-adjuvant (N) | null | 2019-09-03 | null | N | N | ROSCO TRIAL | 101198518 |
| 210003582 | 210010678 | 1.75 | 84.3 | null | 2018-07-05 | 2018-07-20 | Capecitabine | 02 | null | CAPECITABINE | 101592335 |
| 210003589 | 210010680 | 1.71 | 72 | Palliative (P) | 2017-07-02 | 2019-03-25 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100863282 |
| 210003592 | 210010682 | 1.59 | 86.7 | Adjuvant (A) | 2018-11-15 | 2019-03-01 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | 02 | N | PALBOCICLIB | 100779494 |
| 210003593 | 210010683 | 1.64 | 91.6 | Adjuvant (A) | null | 2016-12-10 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101634886 |
| 210003596 | 210010685 | 1.75 | 83.6 | Neo-adjuvant (N) | 2016-06-07 | 2017-07-09 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100932729 |
| 210003598 | 210010686 | 1.61 | 77.5 | Neo-adjuvant (N) | 2018-07-24 | 2018-10-09 | null | null | N | PACLITAXEL + TRASTUZUMAB | 100106900 |
| 210003599 | 210010687 | 1.65 | 89 | null | null | 2020-10-25 | Capecitabine | null | null | CAPECITABINE | 100756826 |
| 210003600 | 210010688 | 1.7 | 46.6 | Neo-adjuvant (N) | null | 2020-05-07 | FEC | N | Y | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100624868 |
| 210003608 | 210010692 | null | 68.9 | null | 2018-04-06 | 2018-04-21 | null | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101459971 |
| 210003609 | 210010693 | 1.56 | 80.5 | Palliative (P) | 2019-10-17 | 2019-10-25 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101869396 |
| 210003610 | 210010694 | 1.57 | 64.4 | null | null | 2018-10-17 | null | 02 | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 101694091 |
| 210003611 | 210010695 | 1.69 | 94 | Adjuvant (A) | 2019-04-02 | 2019-06-13 | Eribulin | 02 | null | ERIBULIN | 100541136 |
| 210003614 | 210010698 | null | null | Palliative (P) | 2019-05-21 | 2019-05-25 | Capecitabine | 02 | N | CAPECITABINE | 100051436 |
| 210003616 | 210010699 | null | null | null | 2019-08-02 | 2019-08-02 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101600708 |
| 210003620 | 210010701 | 1.64 | 62.5 | Adjuvant (A) | 2019-12-18 | 2020-01-02 | Carboplatin + Docetaxel | 02 | N | TRASTUZUMAB EMTANSINE | 101692920 |
| 210003622 | 210010702 | 0 | 71.4 | Curative (C) | 2015-05-21 | 2018-12-21 | PACLITAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | EPIRUBICIN | 100628901 |
| 210003624 | 210010703 | 1.62 | 74.4 | null | 2022-02-23 | 2022-03-05 | Capecitabine | 02 | null | CAPECITABINE | 100189033 |
| 210003628 | 210010705 | null | null | Curative (C) | 2018-10-22 | 2018-11-06 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100983156 |
| 210003634 | 210010708 | 1.61 | 58.9 | Adjuvant (A) | null | 2017-11-24 | FEC + DOCETAXEL | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101537298 |
| 210003637 | 210010710 | 1.79 | 74.1 | Adjuvant (A) | 2021-02-01 | 2021-02-15 | FEC 100 | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100715250 |
| 210003638 | 210010711 | 1.61 | 43.2 | null | 2017-04-10 | 2017-04-30 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100694326 |
| 210003640 | 210010712 | 1.6 | 75.5 | null | null | 2019-09-07 | null | 02 | null | CAPECITABINE + PERTUZUMAB + TRASTUZUMAB | 100230306 |
| 210003641 | 210010713 | 1.58 | 114.4 | Adjuvant (A) | null | 2019-11-05 | FEC 100 | null | N | FEC | 100075897 |
| 210003643 | 210010714 | 1.64 | 88.3 | null | 2021-04-23 | 2021-05-05 | Capecitabine | N | null | CAPECITABINE | 101860198 |
| 210003648 | 210010718 | 1.75 | 57.5 | Neo-adjuvant (N) | 2017-09-06 | 2017-12-13 | Letrozole + Palbociclib | N | N | CARBOPLATIN + DOCETAXEL | 100213352 |
| 210003653 | 210010721 | 1.51 | 79 | null | 2017-07-06 | 2017-09-27 | FEC | null | null | EC | 101719302 |
| 210003655 | 210010723 | 1.6 | 73.5 | Palliative (P) | 2020-02-01 | 2020-02-10 | DOCETAXEL + TRASTUZUMAB | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100450128 |
| 210003662 | 210010726 | 0 | 74.35 | null | 2017-04-23 | 2017-06-04 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | null | TRASTUZUMAB EMTANSINE | 100138986 |
| 210003667 | 210010728 | 1.75 | 85.3 | Neo-adjuvant (N) | 2018-12-01 | 2018-12-24 | FEC 100 | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100691223 |
| 210003668 | 210010729 | null | 75.5 | null | null | 2021-11-23 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100079302 |